- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00481377
Ablation for ICD Intervention Reduction in Patients With CAD (ABLATION 4 ICD)
July 18, 2008 updated by: Institute of Cardiology, Warsaw, Poland
Ablation for ICD Intervention Reduction in Patients With CAD - a Prospective Randomized Trial
The aim of this study is to assess the role of ablation in appropriate ICD interventions reduction in patients with coronary artery disease.
The group will consist of 200 patients with implanted ICD and appropriate intervention in the 3 months prior to enrollment.
The patients will be randomized into ablation arm and conventional treatment.
Number of appropriate ICD interventions is the primary endpoint of this study.
All patients will have control follow-up visits every 3 months.
The follow-up will be based on ICD memory.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mazowieckie
-
Warsaw, Mazowieckie, Poland, 04-628
- Institute of Cardiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Coronary Artery Disease
- ICD implanted
- Appropriate ICD intervention during the 3 months prior to enrollment
- Coronary angiography during the 6 months prior to enrollment
- Possible revascularization
- Age over 18 years
- Signed informed consent
Exclusion Criteria:
- Age less then 18 years
- Pregnancy
- Active participation in other trial
- Heart failure (NYHA IV)
- Contraindications for ablation procedure: i.e. left ventricular thrombus, artificial aortic or mitral valve, no vascular access.
- Monomorphic, incessant, ventricular tachycardia
- Revascularization or other cardio-surgical procedure scheduled in the next 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Number of appropriate ICD interventions
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Quality of life
|
|
Cardiac mortality
|
|
Overall mortality
|
|
Hospitalization due to arrhythmia or heart failure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lukasz J Szumowski, MD, PhD, Institute of Cardiology, Warsaw, Poland
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Study Completion (Anticipated)
May 1, 2010
Study Registration Dates
First Submitted
May 30, 2007
First Submitted That Met QC Criteria
May 31, 2007
First Posted (Estimate)
June 1, 2007
Study Record Updates
Last Update Posted (Estimate)
July 21, 2008
Last Update Submitted That Met QC Criteria
July 18, 2008
Last Verified
July 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IK-NP-0021-42/1013/07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.